Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
36,118,773
-
Shares change
-
+9,804,106
-
Total reported value, excl. options
-
$1,125,171,985
-
Value change
-
+$319,523,410
-
Put/Call ratio
-
3.2%
-
Number of buys
-
61
-
Number of sells
-
-32
-
Price
-
$31.16
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2015
109 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q2 2015.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,118,773 shares
of 183,255,226 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (6,357,294 shares), TANG CAPITAL MANAGEMENT LLC (5,190,837 shares), BAKER BROS. ADVISORS LP (2,807,784 shares), Broadfin Capital, LLC (2,396,681 shares), Partner Fund Management, L.P. (1,811,166 shares), FMR LLC (1,767,161 shares), Cormorant Asset Management, LLC (1,440,000 shares), JANUS CAPITAL MANAGEMENT LLC (1,356,074 shares), STATE STREET CORP (1,198,577 shares), and VHCP Management, LLC (1,095,734 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.